enzalutamide
Marketedupdated 2mo agoby Alessa Therapeutics Inc
Approvedcommunity read0 votes
indications
investigational
Prostate Cancer
all catalysts(28)
approval · 28
Aug 31, 2012
approval
XTANDI (ENZALUTAMIDE) — FDA approval
enzalutamide
→
Mar 19, 2013
approval
XTANDI (ENZALUTAMIDE) — FDA approval
enzalutamide
→
May 23, 2014
approval
XTANDI (ENZALUTAMIDE) — FDA approval
enzalutamide
→
Sep 10, 2014
approval
XTANDI (ENZALUTAMIDE) — FDA approval
enzalutamide
→
Jul 21, 2015
approval
XTANDI (ENZALUTAMIDE) — FDA approval
enzalutamide
→
Aug 5, 2015
approval
XTANDI (ENZALUTAMIDE) — FDA approval
enzalutamide
→
Oct 1, 2015
approval
XTANDI (ENZALUTAMIDE) — FDA approval
enzalutamide
→
Nov 6, 2015
approval
XTANDI (ENZALUTAMIDE) — FDA approval
enzalutamide
→
Jul 14, 2016
approval
XTANDI (ENZALUTAMIDE) — FDA approval
enzalutamide
→
Oct 20, 2016
approval
XTANDI (ENZALUTAMIDE) — FDA approval
enzalutamide
→
Jul 24, 2017
approval
XTANDI (ENZALUTAMIDE) — FDA approval
enzalutamide
→
Jul 13, 2018
approval
XTANDI (ENZALUTAMIDE) — FDA approval
enzalutamide
→
Dec 16, 2019
approval
XTANDI (ENZALUTAMIDE) — FDA approval
enzalutamide
→
News(0)
no news has mentioned this drug yet
comments(0)
5-min edit window · permanent after that